help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2007.061170 on April 6, 2007

Published online before print April 6, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
ajpath.2007.061170v1
170/6/1831    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, Y.
Right arrow Articles by Zhang, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cheng, Y.
Right arrow Articles by Zhang, C.
(American Journal of Pathology. 2007;170:1831-1840.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.061170

MicroRNAs Are Aberrantly Expressed in Hypertrophic Heart

Do They Play a Role in Cardiac Hypertrophy?

Yunhui Cheng*, Ruirui Ji*, Junming Yue{dagger}, Jian Yang*, Xiaojun Liu*, He Chen*, David B. Dean* and Chunxiang Zhang*

From the Cardiovascular Research Laboratory,* Vascular Biology Center and Department of Surgery, University of Tennessee Health Science Center, Memphis, Tennessee; and the Magee Women’s Hospital Research Institute,{dagger} University of Pittsburgh, Pittsburgh, Pennsylvania

MicroRNAs (miRNAs) are a recently discovered class of endogenous, small, noncoding RNAs that regulate gene expression. Although miRNAs are highly expressed in the heart, their roles in heart diseases are currently unclear. Using microarray analysis designed to detect the majority of mammalian miRNAs identified thus far, we demonstrated that miRNAs are aberrantly expressed in hypertrophic mouse hearts. The time course of the aberrant miRNA expression was further identified in mouse hearts at 7, 14, and 21 days after aortic banding. Nineteen of the most significantly dysregulated miRNAs were further confirmed by Northern blot and/or real-time polymerase chain reaction, in which miR-21 was striking because of its more than fourfold increase when compared with the sham surgical group. Similar aberrant expression of the most up-regulated miRNA, miR-21, was also found in cultured neonatal hypertrophic cardiomyocytes stimulated by angiotensin II or phenylephrine. Modulating miR-21 expression via antisense-mediated depletion (knockdown) had a significant negative effect on cardiomyocyte hypertrophy. The results suggest that miRNAs are involved in cardiac hypertrophy formation. miRNAs might be a new therapeutic target for cardiovascular diseases involving cardiac hypertrophy such as hypertension, ischemic heart disease, valvular diseases, and endocrine disorders.





This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Nishi, K. Ono, Y. Iwanaga, T. Horie, K. Nagao, G. Takemura, M. Kinoshita, Y. Kuwabara, R. T. Mori, K. Hasegawa, et al.
MicroRNA-15b Modulates Cellular ATP Levels and Degenerates Mitochondria via Arl2 in Neonatal Rat Cardiac Myocytes
J. Biol. Chem., February 12, 2010; 285(7): 4920 - 4930.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. Condorelli, M. V.G. Latronico, and G. W. Dorn II
microRNAs in heart disease: putative novel therapeutic targets?
Eur. Heart J., January 29, 2010; (2010): ehp573v1 - ehp573.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Abdellatif
The Role of MicroRNA-133 in Cardiac Hypertrophy Uncovered
Circ. Res., January 8, 2010; 106(1): 16 - 18.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. J. Matkovich, W. Wang, Y. Tu, W. H. Eschenbacher, L. E. Dorn, G. Condorelli, A. Diwan, J. M. Nerbonne, and G. W. Dorn II
MicroRNA-133a Protects Against Myocardial Fibrosis and Modulates Electrical Repolarization Without Affecting Hypertrophy in Pressure-Overloaded Adult Hearts
Circ. Res., January 8, 2010; 106(1): 166 - 175.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Schroen and S. Heymans
MicroRNAs and Beyond: The Heart Reveals Its Treasures
Hypertension, December 1, 2009; 54(6): 1189 - 1194.
[Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Chirayil, R. Chirayil, and K. J. Luebke
Discovering ligands for a microRNA precursor with peptoid microarrays
Nucleic Acids Res., September 1, 2009; 37(16): 5486 - 5497.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
D. Catalucci, P. Gallo, and G. Condorelli
MicroRNAs in Cardiovascular Biology and Heart Disease
Circ Cardiovasc Genet, August 1, 2009; 2(4): 402 - 408.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Cheng, X. Liu, J. Yang, Y. Lin, D.-Z. Xu, Q. Lu, E. A. Deitch, Y. Huo, E. S. Delphin, and C. Zhang
MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation
Circ. Res., July 17, 2009; 105(2): 158 - 166.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M. Kato, L. Arce, and R. Natarajan
MicroRNAs and Their Role in Progressive Kidney Diseases
Clin. J. Am. Soc. Nephrol., July 1, 2009; 4(7): 1255 - 1266.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X.-P. Ren, J. Wu, X. Wang, M. A. Sartor, J. Qian, K. Jones, P. Nicolaou, T. J. Pritchard, and G.-C. Fan
MicroRNA-320 Is Involved in the Regulation of Cardiac Ischemia/Reperfusion Injury by Targeting Heat-Shock Protein 20
Circulation, May 5, 2009; 119(17): 2357 - 2366.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Ikeda, A. He, S. W. Kong, J. Lu, R. Bejar, N. Bodyak, K.-H. Lee, Q. Ma, P. M. Kang, T. R. Golub, et al.
MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes
Mol. Cell. Biol., April 15, 2009; 29(8): 2193 - 2204.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Lin, X. Liu, Y. Cheng, J. Yang, Y. Huo, and C. Zhang
Involvement of MicroRNAs in Hydrogen Peroxide-mediated Gene Regulation and Cellular Injury Response in Vascular Smooth Muscle Cells
J. Biol. Chem., March 20, 2009; 284(12): 7903 - 7913.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Y. Lu, J. Xiao, H. Lin, Y. Bai, X. Luo, Z. Wang, and B. Yang
A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference
Nucleic Acids Res., February 1, 2009; 37(3): e24 - e24.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. F. Duisters, A. J. Tijsen, B. Schroen, J. J. Leenders, V. Lentink, I. van der Made, V. Herias, R. E. van Leeuwen, M. W. Schellings, P. Barenbrug, et al.
miR-133 and miR-30 Regulate Connective Tissue Growth Factor: Implications for a Role of MicroRNAs in Myocardial Matrix Remodeling
Circ. Res., January 30, 2009; 104(2): 170 - 178.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J.-F. Chen, T. E. Callis, and D.-Z. Wang
microRNAs and muscle disorders
J. Cell Sci., January 1, 2009; 122(1): 13 - 20.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. Divakaran and D. L. Mann
The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure
Circ. Res., November 7, 2008; 103(10): 1072 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. van Rooij, W. S. Marshall, and E. N. Olson
Toward MicroRNA-Based Therapeutics for Heart Disease: The Sense in Antisense
Circ. Res., October 24, 2008; 103(9): 919 - 928.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. A. da Costa Martins, M. Bourajjaj, M. Gladka, M. Kortland, R. J. van Oort, Y. M. Pinto, J. D. Molkentin, and L. J. De Windt
Conditional Dicer Gene Deletion in the Postnatal Myocardium Provokes Spontaneous Cardiac Remodeling
Circulation, October 7, 2008; 118(15): 1567 - 1576.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. van Rooij, L. B. Sutherland, J. E. Thatcher, J. M. DiMaio, R. H. Naseem, W. S. Marshall, J. A. Hill, and E. N. Olson
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
PNAS, September 2, 2008; 105(35): 13027 - 13032.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Thum, D. Catalucci, and J. Bauersachs
MicroRNAs: novel regulators in cardiac development and disease
Cardiovasc Res, September 1, 2008; 79(4): 562 - 570.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Yang, Y. Lu, and Z. Wang
Control of cardiac excitability by microRNAs
Cardiovasc Res, September 1, 2008; 79(4): 571 - 580.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
D. Sayed, S. Rane, J. Lypowy, M. He, I.-Y. Chen, H. Vashistha, L. Yan, A. Malhotra, D. Vatner, and M. Abdellatif
MicroRNA-21 Targets Sprouty2 and Promotes Cellular Outgrowths
Mol. Biol. Cell, August 1, 2008; 19(8): 3272 - 3282.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. V. G. Latronico, D. Catalucci, and G. Condorelli
MicroRNA and cardiac pathologies
Physiol Genomics, August 1, 2008; 34(3): 239 - 242.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. G. Romero, M. W. Plonczynski, C. A. Carvajal, E. P. Gomez-Sanchez, and C. E. Gomez-Sanchez
Microribonucleic Acid-21 Increases Aldosterone Secretion and Proliferation in H295R Human Adrenocortical Cells
Endocrinology, May 1, 2008; 149(5): 2477 - 2483.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Zhang
MicroRNomics: a newly emerging approach for disease biology
Physiol Genomics, April 1, 2008; 33(2): 139 - 147.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. V.G. Latronico, D. Catalucci, and G. Condorelli
Emerging Role of MicroRNAs in Cardiovascular Biology
Circ. Res., December 7, 2007; 101(12): 1225 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
E. van Rooij and E. N. Olson
microRNAs put their signatures on the heart
Physiol Genomics, November 14, 2007; 31(3): 365 - 366.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society for Investigative Pathology.